Literature DB >> 36051225

A complication in a patient with hidradenitis suppurativa taking adalimumab.

Olivia D Perez1, Meera Tarazi2, Sameera Husain2, Jasnit Makkar3, Stephanie M Gallitano2.   

Abstract

Entities:  

Keywords:  HPV, human papilloma virus; HS, hidradenitis suppurativa; SCC, squamous cell carcinoma; hidradenitis suppurativa; malignant transformation; squamous cell carcinoma

Year:  2022        PMID: 36051225      PMCID: PMC9424257          DOI: 10.1016/j.jdcr.2022.05.045

Source DB:  PubMed          Journal:  JAAD Case Rep        ISSN: 2352-5126


× No keyword cloud information.

Description

A 54-year-old man with a 25-year history of Hurley stage III hidradenitis suppurativa (HS) and inflammatory arthritis presented to the emergency department with worsening groin lesions with increasing pain and drainage. His treatment for HS and arthritis included 40-mg adalimumab weekly and 17.5-mg methotrexate weekly for 5 years. He had not seen a dermatologist in 2 years. His prescriptions were filled by another provider. On physical examination, the patient appeared cachectic. He was both tachycardic and tachypneic. The sacrum, mons pubis, scrotum, and penis had multiple coalescing draining sinuses and subcutaneous nodules and plaques. There was a large fungating ulcer in the left inguinal fold (Fig 1). A biopsy was performed of the large ulcer (Fig 2), and cross-sectional imaging of the patient was obtained (Fig 3).
Fig 1
Fig 2
Fig 3
Question 1: What is the most likely diagnosis? Perianal cutaneous Crohn disease Granuloma inguinale Noduloulcerative syphilis Poorly controlled hidradenitis suppurativa Squamous cell carcinoma (SCC) Answer: Perianal cutaneous Crohn disease – Incorrect. Perianal cutaneous Crohn disease is a rare cutaneous disorder characterized by perianal fissures and fistulas. Histopathology reveals noncaseating granulomas infiltrating with multinucleate giant cells, lymphocytes, eosinophils, and plasma cells. Granuloma inguinale – Incorrect. It is a genital ulcerative disease caused by Klebsiella granulomatis and rarely occurs in the United States. The disease is characterized by slowly progressive painless lesions on the genital and perineal regions, although subcutaneous granulomas can occur. The lesions are highly vascular with a beefy-red appearance and can bleed. Histopathology demonstrates intrahistiocytic gram-negative rods, consistent with Donovan bodies. Noduloulcerative syphilis – Incorrect. Also known as malignant syphilis, noduloulcerative syphilis is a rare manifestation of syphilis, most commonly seen in HIV-infected patients, and presents with necrotic and ulcerative papules and nodules in various stages of development. Lesions respond rapidly to treatment with penicillin. Poorly controlled hidradenitis suppurativa – Incorrect. This patient has suffered a complication of longstanding, poorly controlled HS. SCC – Correct. Malignant transformation to SCC is a well-established complication of HS and carries a poor prognosis.5, 6, 7 A retrospective study of tissue samples taken from 217 patients with HS showed a prevalence of SCC in 4.6% of patients. The pathophysiology of development of SCC from chronic HS is multifactorial and involves an immune response to ruptured follicles. Malignant transformation predominantly occurs in gluteal and perianal regions rather than axillary regions. Question 2: Which of the following is a well-established etiological risk factor for developing SCC in HS? Adalimumab use Recent development of HS Human papilloma virus (HPV) infection Increased body mass index Radical surgery of HS lesions Answer: Adalimumab use – Incorrect. There have been case reports in the literature of patients with HS taking adalimumab and other tumor necrosis factor-α antagonists who went on to develop SCC; however, the role of biological immunosuppressants in malignant transformation of HS is an area in need of more research. Recent development of HS – Incorrect. Longstanding HS is associated with malignant transformation to SCC. HPV infection – Correct. HPV infection is a known risk factor of development of SCC. High-risk HPV strains 16, 18, 31, and others express oncoproteins E6 and E7 which induce DNA damage and aneuploidy. HPV DNA also integrates itself in the host genome, and together these mechanisms contribute to genomic instability that underlie development of SCC. Increased body mass index – Incorrect. This is not a known risk factor of malignant transformation from HS to SCC. Radical surgery of HS lesions – Incorrect. Radical surgery is not a known risk factor of malignant transformation from HS to SCC. Surgery is a treatment method that provides a chance for cure of SCC. Question 3: Development of squamous cell carcinoma (SCC) is a known complication of chronic, long-standing HS with a reported incidence of 1% to 3.4%. Which patient demographic with HS is at greatest risk of developing SCC? A female patient with longstanding HS A female patient with recent-onset HS A male patient with longstanding HS A male patient with recent-onset HS Answer: A female patient with longstanding HS – Incorrect, male patients with longstanding HS are at greatest risk of developing SCC. A female patient with recent-onset HS – Incorrect, female patient with recent-onset HS are at greatest risk of developing SCC. A male patient with longstanding HS – Correct. Although HS is 3 times more common in women, between 86% and 100% of cases of HS complicated by SCC are reported to be in men., The risk of malignant transformation increases with duration since HS diagnosis and the average time from onset of HS to SCC diagnosis is about 25 years. A male patient with recent-onset HS – Incorrect, male patient with recent-onset HS are at greatest risk of developing SCC.

Conflicts of interest

None disclosed.
  13 in total

Review 1.  Squamous cell carcinoma in the setting of chronic hidradenitis suppurativa; report of a patient and update of the literature.

Authors:  Zachary G Pena; Raja K Sivamani; Thomas H Konia; Daniel B Eisen
Journal:  Dermatol Online J       Date:  2015-04-16

Review 2.  Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa.

Authors:  C Lavogiez; E Delaporte; S Darras-Vercambre; E Martin De Lassalle; C Castillo; X Mirabel; F Laurent; P Patenotre; T Gheit; J C Talmant; M Beylot-Barry; V Martinot; F Piette; F Aubin; L Mortier
Journal:  Dermatology       Date:  2009-12-23       Impact factor: 5.366

3.  Squamous cell carcinoma complicating chronic suppurative hydradenitis.

Authors:  Julian E Losanoff; Paula Sochaki; Nabiha Khoury; Edi Levi; Walter A Salwen; Marc D Basson
Journal:  Am Surg       Date:  2011-11       Impact factor: 0.688

4.  Sexually Transmitted Infections Treatment Guidelines, 2021.

Authors:  Kimberly A Workowski; Laura H Bachmann; Philip A Chan; Christine M Johnston; Christina A Muzny; Ina Park; Hilary Reno; Jonathan M Zenilman; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2021-07-23

Review 5.  Dermatologic manifestations of inflammatory bowel disease: a review.

Authors:  Uma Keyal; Yeqiang Liu; Anil Kumar Bhatta
Journal:  Discov Med       Date:  2018-05       Impact factor: 2.970

6.  Hidradenitis suppurativa complicated by squamous cell carcinoma.

Authors:  Constantinos Constantinou; Kenneth Widom; Joseph Desantis; Melissa Obmann
Journal:  Am Surg       Date:  2008-12       Impact factor: 0.688

7.  Granuloma inguinale in a 51-year-old man.

Authors:  Jennifer Ornelas; Maija Kiuru; Thomas Konia; Larissa Larsen
Journal:  Dermatol Online J       Date:  2016-04-18

Review 8.  [Malignant syphilis in patient with human immunodeficiency virus (HIV): case report and literature review].

Authors:  M J Romero-Jiménez; I Suárez Lozano; J M Fajardo Picó; B Barón Franco
Journal:  An Med Interna       Date:  2003-07

9.  Squamous Cell Carcinoma in Hidradenitis Suppurativa Lesions Following Tumor Necrosis Factor α Inhibitors.

Authors:  Shaun D Cooper; Molly C E Cowdrey; Konstantinos D Linos; Joel A Lefferts; Katherina K Basic
Journal:  Cutis       Date:  2021-04

10.  Metastatic squamous cell carcinoma in a patient treated with adalimumab for hidradenitis suppurativa.

Authors:  Rachel Giesey; Gregory R Delost; Jeremy Honaker; Neil J Korman
Journal:  JAAD Case Rep       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.